Hidehito Horinouchi: ATORG expert consensus statement on the peri-operative management of NSCLC
A recent paper by Stephanie Saw, Medical Oncologist at National Cancer Centre Singapore, was mentioned by Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, on X:
Authors: Stephanie Saw, Wen-Zhao Zhong, Rui Fub, Thanyanan Reungwetwattana, Navneet Singh et al.
“Asian Thoracic Oncology Research Group (ATORG) expert consensus statement on the peri-operative management of NSCLC.”
More posts featuring Hidehito Horinouchi.
Hidehito Horinouchi is the Assistant Chief of the National Cancer Center Hospital. He also serves as the Secretary General of the Lung Cancer Study Group, Japan Clinical Oncology Group, and the Deputy Chief of the Center for Education and Professional Career Development at the National Cancer Center Hospital.
He specializes in multimodal treatment strategies, including medical, surgical, and radiation oncology, for patients with thoracic malignancies.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023